The Fine Print Blog

by Alison Mehlman
CHLP Director of Planning & Policy Research

It appears as if some physicians in New York State feel that their time and convenience should be a primary determinant of HIV testing policy. But what has happened to patient-centered care? Should the perceived inconvenience of a health care provider trump the enforcement of necessary patient protections?

by Catherine Hanssens
CHLP Executive Director

A flurry of outraged discussion has continued in the wake of the voiced objections of Colorado State Senator Dave Schultheis to a bill, SB-179, which would, among other things, require HIV testing of all pregnant women who don’t explicitly object to the testing.

by Catherine Hanssens
CHLP Executive Director

Given what we know about the near-zero risk of HIV transmission from health care worker to patient, even during so-called exposure-prone procedures, it’s past time that the nation’s public health authority acknowledges that their own guidelines are too restrictive.

by Bill Piper
Director, National Affairs
Drug Policy Alliance

According to news reports, President-elect Obama is considering nominating Republican Congressman Jim Ramstad (R-MN) to be the next director of the Office of National Drug Control Policy (ONDCP) or "drug czar." That would be a mistake.

by Joseph Sonnabend, M.D.,
CHLP Medical Resource Specialist,
and Ashley Burczak,
CHLP Program and Development Associate

All across the country, at AIDS conferences and medical provider “summits,” and from professional organizations such as the American Academy of Pediatrics, we hear the call for dispensing with informed consent in HIV testing to a more doctor-centered approach—“opt-out” testing—which relieves health care providers of the obligation to explain HIV and its consequences before testing patients for it.


Subscribe to